This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Vincent Bordas - Innovator in Pharmaceutical Applications
Introduction: Vincent Bordas is an inventor based in Basel, Switzerland. He is currently associated with Novartis AG, a leading global healthcare company. Although he has not yet been granted any patents, his work focuses on significant pharmaceutical innovations.
Latest Patent Applications: Vincent Bordas has submitted a patent application for an N-oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea. This application describes the compound, its pharmaceutically acceptable salts, and methods of preparing the compound and compositions. The application also outlines methods for using the compound and compositions to treat various diseases by inhibiting kinase activity selected from FGFR1, FGFR2, FGFR3, or FGFR4.
Conclusion: Vincent Bordas is a promising inventor in the pharmaceutical field, contributing to innovative applications that may lead to significant advancements in medical treatments. His ongoing work at Novartis AG highlights his commitment to developing effective solutions for various health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile